Jadoon Raheel Jahangir, Jalal-ud-Din Mir, Khan Sher Ali
Department of Medicine, Women Medical College, BBS Teaching Hospital, Abbottabad.
J Coll Physicians Surg Pak. 2015 Nov;25(11):824-7.
To determine the frequency of E. coli resistance to ciprofloxacin and common factors leading to it among patients presenting with urinary tract infection.
Descriptive cross-sectional study.
Department of Medicine, Ayub Teaching Hospital, Abbottabad, from December 2011 to June 2012.
A total of 166 patients, > 18 years of age of both gender, who presented with features of UTI and had urine culture positive for E.coli were included in the study. The urine samples were further tested for ciprofloxacin resistance and the patients were further checked for the common factors leading to E.coli resistance to ciprofloxacin.
Among 166 patients, 41 were male and 125 were female patients. Sixty-six (39.8%) E. coli isolates showed ciprofloxacin resistance. Male gender (p-value 0.001), previous history of recurrent UTI (p = 0.008, OR = 2.37), history of prior use of ciprofloxacin (p = 0.018, OR = 2.16) and history of catheterization (p = 0.005, OR = 4.80) were independent risk factors found in this study for the development of ciprofloxacin resistant UTIs.
Ciprofloxacin resistance rates of E.coli were high at over 39.8%. The risk factors that affected the ciprofloxacin resistance rates of E.coli were prior use of ciprofloxacin, recurrent UTI, previous catheterization and male gender. Ciprofloxacin should be prescribed cautiously in patients with these risk factors and urine culture and sensitivity test should be performed for optimal treatment.
确定尿路感染患者中大肠杆菌对环丙沙星的耐药频率及其常见的耐药因素。
描述性横断面研究。
2011年12月至2012年6月,阿伯塔巴德阿尤布教学医院内科。
本研究纳入了166例年龄超过18岁、有尿路感染症状且尿液培养大肠杆菌呈阳性的患者,无论男女。对尿液样本进一步检测环丙沙星耐药情况,并对患者进一步检查导致大肠杆菌对环丙沙星耐药的常见因素。
166例患者中,男性41例,女性125例。66株(39.8%)大肠杆菌分离株显示对环丙沙星耐药。本研究发现男性(p值0.001)、既往复发性尿路感染史(p = 0.008,OR = 2.37)、既往使用环丙沙星史(p = 0.018,OR = 2.16)和导尿史(p = 0.005,OR = 4.80)是环丙沙星耐药性尿路感染发生的独立危险因素。
大肠杆菌对环丙沙星的耐药率较高,超过39.8%。影响大肠杆菌对环丙沙星耐药率的危险因素包括既往使用环丙沙星、复发性尿路感染、既往导尿史和男性。对于有这些危险因素的患者,应谨慎使用环丙沙星,并应进行尿培养和药敏试验以进行最佳治疗。